Trials / Completed
CompletedNCT00891241
A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
A Multi-Center, Single Dose, Phase I, Dosimetry, Biodistribution, and Safety Trial of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Lantheus Medical Imaging · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical study is to estimate the safety and radiation dosimetry of a single dose of LMI1195 in healthy subjects and heart failure patients undergoing positron emission tomography (PET)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LMI 1195-101 | Single dose, bolus IV injection of LMI 1195 |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2009-05-01
- Last updated
- 2020-11-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00891241. Inclusion in this directory is not an endorsement.